PHR:NYSEPhreesia, Inc. Analysis
Data as of 2026-09-02 - not real-time
$11.97
Latest Price
8/10Risk
Risk Level: High
Executive Summary
At $11.96, Phreesia, Inc. shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have gained 19.5%. Momentum indicators put RSI at 54.8 (neutral) with MACD reading bearish. Watch $11.21 as support and $13.01 as the nearer resistance level.
On valuation the read is fair — earnings multiple of 74.8 versus a 30.9 sector average, above the peer group. Sell-side targets cluster 16.5% above the current quote. Revenue is growing at 12.9% on a 1.9% profit margin.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 49.9%, a beta of 0.36 and a maximum drawdown of 74.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
On valuation the read is fair — earnings multiple of 74.8 versus a 30.9 sector average, above the peer group. Sell-side targets cluster 16.5% above the current quote. Revenue is growing at 12.9% on a 1.9% profit margin.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 49.9%, a beta of 0.36 and a maximum drawdown of 74.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
Phreesia Inc. PHR Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire LOS...Phreesia Inc. PHR Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire LOS...Updated Jun 3, 2026 0 SAN DIEGO-- BUSINESS WIRE --Jun 3, 2026-- Robbins LLP reminds stockholders that a class action...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 12.40
- MACD momentum is negative
- 30-day price change of +19.5%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 74.8 versus sector average of 30.9
- Trading below the 200-day average of 12.40
- Analyst targets imply +16.5% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 74.8 versus sector average of 30.9
- Analyst targets imply +16.5% versus the current price
- Revenue growth of +12.9%
Key Metrics & Analysis
Financial Health
Revenue Growth12.90%
Profit Margin1.85%
P/E Ratio74.8
ROE2.86%
ROA1.48%
Debt/Equity25.77
P/B Ratio2.1
Op. Cash Flow$87.9M
Free Cash Flow$56.4M
Industry P/E30.9
Technical Analysis
TrendNeutral
RSI54.8
Support$11.21
Resistance$13.01
MA 20$11.99
MA 50$11.17
MA 200$12.40
MACDBearish
VolumeDecreasing
Fear & Greed Index93.71
Valuation
Fair Value$19.53
Target Price$13.94
Upside/Downside16.52%
GradeFair
TypeGrowth
Risk Assessment
Beta0.36
Volatility49.95%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.